- Home
- Multidose Pump Systems
- SP270+ and SP370+
SP270+ and SP370+
Pumps and actuators for Ear, Nose, Throat delivery
SP270+/SP370+: quality and performance for ENT sprays in regulated markets
SP270+ and SP370+ are our versatile pumps for both Rx/ OTC drug products and medical devices for ear, nose and throat sprays.
They comply with regulated markets requirements.
To watch this video you must consent the use of cookies.
Versatile pumps for Rx/ OTC drug products and medical devices for ear, nose and throat sprays.
The SP270+ and SP370+ are our versatile pump platforms for ear, nose and throat spray delivery.
Based on the same engine technology, this platform offers the modularity you need.
The extensive range of actuators available makes these pumps easily adaptable for nasal, buccal and auricular liquid formulations, for the convenient and safe delivery of drugs to patients.
Customized versions of the SP270+ are also available with in-vitro bioequivalence performance for the main nasal suspensions.
- Very good dose consistency
- Wide range of dose volumes: 50 μl to 200 μl with different actuators
- Various neck finishes: screw-on, snap-on and crimp-on
- Large choice of actuators with various designs and spray characteristics
- Suitable for liquid solutions and suspensions
- Compatible with Spray Lock child-resistant solution
- Precise and consistent dose delivered until end of life
- Several drug products references on the European, U.S. and Japanese markets
- IVBE expertise
- Track record with large scale GMP manufacturing
- Compatible with plastic and glass containers
Our ENT featured services
Comparative in vitro performance studies designed to support regulatory submissions and generic development programs.
Comprehensive assessment of shot weight, droplet size distribution, spray plume and plume geometry to support formulation and device development.
Evaluation of deposition profiles to optimize delivery performance and support systemic intranasal drug delivery programs.
Support covering regulatory strategy, submission authoring, human factors engineering and combination product development activities.
SP270+ and SP370+ in the press
Integrated turnkey solutions
Discover the articleRelated products
In-vitro Bioequivalence for nasal sprays
Based on FDA requirements, we have established a Device Equivalence Program in order to accelerate time-to-market and achieve bioequivalence requirements.
Discover More
SP27 and SP37
SP27 and SP37 are our cost-competitive pump systems for ear, nose and throat sprays.
Discover More
Have a question?
We are here to help!